Marie B. B.
- Country
- France
- Department
- DERMATOLOGIE SAINT ANDRE
Research Overview
- Evaluation of a Drug Combination in Patients with Cutaneous T-cell Lymphomas (CTCL)
- A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate Pembrolizumab Versus Placebo as Adjuvant Therapy Following Surgery and Radiation in Participants with High-risk Locally Advanced Cutaneous Squamous Cell Carcinoma (LA cSCC) (KEYNOTE-630).
- A Multicenter, Open-label, Phase 3 Study to Evaluate the Long-term Safety and Efficacy in Participants who are Currently on Treatment or in Follow-up in Studies That Include Pembrolizumab
Data & Insights
Has run more than one trial at 89 of 298 partner sites.
Specializations
Dermatologic Oncology
This investigator specializes in treating advanced forms of cutaneous squamous cell carcinoma (cSCC), conducting research across various stages of the disease from locally advanced to metastatic presentations. Their work encompasses both adjuvant therapy approaches and treatments for patients with unresectable conditions.
- Advanced cSCC Management
- Immunotherapy Applications
- Post-surgical Treatment Strategies
Lymphoma Research
The investigator focuses on innovative treatments for cutaneous T-cell lymphoma (CTCL), including specific subtypes such as Mycosis Fungoides and Sézary Syndrome. Their research extends to both early-stage and advanced disease management.
- T-Cell Lymphoma Therapeutics
- Novel Monoclonal Antibody Treatments
- Combined Therapy Approaches
Inflammatory Skin Conditions
Research activities include treatments for recurrent aphthous stomatitis, generalized pustular psoriasis, and moderate acne in diverse patient populations. The investigator explores both conventional and innovative therapeutic approaches.
- Severe Oral Ulcers
- Psoriasis Management
- Acne Treatment Optimization
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.